Bionano Genomics, Inc. (BNGO)

Bionano Genomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.63	9.17	17.95	5.09	24.57	38.45
Short-Term Investments	14.61	0.3	48.82	108.1	226.04	-
Cash & Short-Term Investments	18.23	9.48	66.77	113.19	250.61	38.45
Cash Growth	-35.63%	-85.81%	-41.01%	-54.84%	551.80%	122.10%
Accounts Receivable	3.35	4.75	9.32	7.02	4.93	2.78
Other Receivables	-	0.02	0.34	0.47	-	-
Receivables	3.35	4.77	9.66	7.5	4.93	2.78
Inventory	9.56	11.12	22.89	29.76	12.39	3.32
Prepaid Expenses	2.78	0.7	1.1	1.39	4.48	0.64
Other Current Assets	11	13.42	39.69	5.47	-	1.61
Total Current Assets	44.93	39.49	140.12	157.3	272.41	46.79
Property, Plant & Equipment	22.7	24.32	32.48	28.96	20.94	4.91
Goodwill	-	-	-	77.29	56.16	7.17
Other Intangible Assets	8.37	9.71	33.97	41.14	26.84	1.48
Other Long-Term Assets	2.42	3.15	7.83	2.81	0.75	0.1
Total Assets	78.41	76.67	214.4	307.5	377.1	60.45
Accounts Payable	6.56	6.96	10.38	12.53	10.77	2.93
Accrued Expenses	2.71	4.62	6.58	9.22	6.94	4.36
Short-Term Debt	13.04	20.36	69.8	-	-	-
Current Portion of Leases	1.85	3.25	2.44	2.55	1.77	-
Current Income Taxes Payable	0.66	0.73	1.1	0.83	0.68	0.56
Current Unearned Revenue	1.02	1.13	0.78	0.87	0.68	0.42
Other Current Liabilities	0.57	0.29	8.94	9.89	1	0.68
Total Current Liabilities	26.41	37.34	100.03	35.88	21.84	8.95
Long-Term Debt	-	-	-	-	-	16.33
Long-Term Leases	3.53	3.68	7.18	9.12	8.93	-
Long-Term Unearned Revenue	0.29	0.27	0.15	0.13	0.15	0.1
Other Long-Term Liabilities	-	-	10.89	12.97	9.07	-
Total Liabilities	30.23	41.3	118.25	58.1	39.98	25.37
Common Stock	-	-	-	0	0.03	0.02
Additional Paid-In Capital	744.5	728.57	677.34	599.23	553.75	178.75
Retained Earnings	-696.33	-693.23	-581.21	-348.72	-216.12	-143.68
Comprehensive Income & Other	0.01	0.03	0.02	-1.12	-0.54	-
Total Common Equity	48.19	35.38	96.16	249.4	337.12	35.08
Shareholders' Equity	48.19	35.38	96.16	249.4	337.12	35.08
Total Liabilities & Equity	78.41	76.67	214.4	307.5	377.1	60.45
Total Debt	18.42	27.3	79.41	11.67	10.7	16.33
Net Cash (Debt)	-0.18	-17.82	-12.64	101.52	239.92	22.12
Net Cash Growth	-	-	-	-57.69%	984.42%	-
Net Cash Per Share	-0.11	-14.02	-22.22	210.61	520.08	127.33
Filing Date Shares Outstanding	3.36	3.01	0.91	0.51	0.48	0.46
Total Common Shares Outstanding	3.1	1.87	0.76	0.5	0.48	0.32
Working Capital	18.52	2.15	40.09	121.41	250.57	37.84
Book Value Per Share	15.54	18.96	126.10	503.52	698.44	110.81
Tangible Book Value	39.82	25.67	62.18	130.97	254.12	26.43
Tangible Book Value Per Share	12.84	13.76	81.55	264.41	526.48	83.50
Machinery	-	42.76	38.68	27.11	16.72	10.48
Leasehold Improvements	-	3.33	3.75	4	2.67	1.89

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q